Dynamic ctDNA Monitoring Predicts Recurrence and Guides Therapy in Postoperative Hepatocellular Carcinoma
Blood-based tumor DNA monitoring after liver cancer surgery detects recurrence earlier than standard blood tests, potentially enabling timely treatment.
This Journal of Surgical Oncology study demonstrates that dynamic ctDNA monitoring post-hepatectomy predicts HCC recurrence earlier than standard biomarkers and can guide adjuvant therapy decisions. The approach addresses the major clinical challenge of high recurrence rates in HCC after surgery.
What the study was
- Study design
- Prospective biomarker study
- Population
- Postoperative HCC patients
- Category
- Early Detection
- Maturity
- Exploratory
- Journal
- Journal of surgical oncology
Why it surfaced
ctDNA recurrence monitoring in post-op HCC fills a major unmet need; directly actionable for surveillance/therapy guidance in a high-recurrence disease.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.